HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gut-Brain Axis Study On Haleon Probiotic Shows ‘Subtle’ Effects On Psychological Health

Executive Summary

Haleon’s Puraflor probiotic when taken daily by adults was shown to alter gray matter volume and brain response patterns, according to a study published in the journal Cells.

You may also be interested in...



Probi Offers New Option In Growing Brain Health Probiotics Market

Swedish probiotics developer Probi has a new offering for dietary supplement manufacturers looking to tap into the fast growing brain health market. The company has also made its first foray into synbiotics with partner Clasado.

ADM Protexin Launches Vitamin-Enriched Probiotic, Investigates Gut-Brain Axis

To help brighten up summer for UK consumers,  ADM Protexin has added a vitamin-enriched food supplement to its Bio-Kult line of probiotics. The firm also profiles a recent clinical trial showing promise for probiotic-related mood improvement in a short documentary. 

‘Uniquely Positioned’ In Probiotics, IFF Emphasizes Ingredients For Women's, Cognitive, Skin Health

Jennifer Montgomery, IFF’s probiotics marketing manager for the Americas, responds to HBW Insight questions about the firm’s plans to deliver probiotics ingredients and technologies following the recent closing of its acquisition of DuPont Nutrition & Biosciences through a merger agreement.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152945

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel